Stay updated on IPF/ILD-PRO Clinical Trial of Novel Therapy
Sign up to get notified when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.

Latest updates to the IPF/ILD-PRO Clinical Trial of Novel Therapy page
- Check6 days agoChange DetectedCharlottesville, VA site added with its contact number. Baltimore, MD location and Maryland listing removed; phone number formatting updated from 2164450574 to 216-445-0574.SummaryDifference0.3%

- Check13 days agoChange DetectedNew investigators and contact details were added (e.g., Surya Olguin, Sally Suliman, Summer Zhu, Mary Strek, Mona Noroozi, etc.) and the contact/locations information was updated. The study locations now total 41.SummaryDifference3%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the site revision to v3.4.1 (replacing v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page adds a Show glossary option and updates metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data) with a Revision: v3.4.0. These are UI and data-label changes rather than substantive updates to study content or eligibility; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing state recruitment sites and updated the study revision to v3.3.3; removed the previous per-state location blocks and the HHS Vulnerability Disclosure link.SummaryDifference2%

Stay in the know with updates to IPF/ILD-PRO Clinical Trial of Novel Therapy
Enter your email address, and we'll notify you when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.